Skip to search.
 TSX Down 0.01% TSX Ventures Up 0.78%

Novavax, Inc. (NVAX)

-NasdaqGS
9.16 Down 0.15(1.61%) 4:00PM EST
|After Hours : 9.15 Down 0.01 (0.11%) 4:14PM EST - Nasdaq Real Time Price
Add to Portfolio
Prev Close:9.31
Open:8.65
Bid:9.15 x 18300
Ask:9.16 x 26400
1y Target Est:9.58
Beta:0.73
Next Earnings Date:N/A
Day's Range:8.51 - 9.24
52wk Range:3.34 - 9.83
Volume:5,035,222
Avg Vol (3m):4,961,580
Market Cap:2.18B
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVAXDown 1.61%2.18B
MRKDown 0.71%166.89B
NVSDown 0.58%245.62B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):67.92
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.33
Quarterly EPS Est (Mar-15) :-0.09
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback